BlueCrest Capital Management’s Elanco Animal Health ELAN Stock Holding History

BlueCrest Capital Management’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-56,479	Closed	-$1.8M	–	324
2021 Q3	$1.8M	Buy	56,479 +21,627	+62%	+$726K	0.05%	223
2021 Q2	$1.21M	Buy	+34,852	New	+$1.15M	0.02%	370
2019 Q2	–	Sell	-2,395,203	Closed	-$76.8M	–	610
2019 Q1	$76.8M	Buy	2,395,203 +2,383,734	+20,784%	+$73.4M	3.07%	2
2018 Q4	$362K	Sell	11,469 -196,085	-94%	-$6.42M	0.02%	448
2018 Q3	$7.24M	Buy	+207,554	New	+$7.3M	0.19%	77

Other funds holding ELAN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlueCrest Capital Management's ELAN Position: Q4 2021 in Review

BlueCrest Capital Management sold out of Elanco Animal Health (ELAN) in Q4 2021, closing a stake of 56,479 shares — an estimated $1.8M sold.

BlueCrest Capital Management first reported a position in ELAN in Q3 2018 and held it in 5 quarters. The position peaked at $76.8M in Q1 2019. 480 funds tracked by Wall St. Rank hold ELAN as of Q4 2021.

BlueCrest Capital Management reported no remaining Elanco Animal Health position as of Q4 2021 after selling out during the quarter.
BlueCrest Capital Management sold 56,479 Elanco Animal Health shares in Q4 2021, an estimated $1.8M.
BlueCrest Capital Management first reported a position in Elanco Animal Health in Q3 2018 and held it in 5 quarters.
BlueCrest Capital Management's Elanco Animal Health position peaked at $76.8M in Q1 2019.
480 funds tracked by Wall St. Rank held Elanco Animal Health as of Q4 2021.

Based on BlueCrest Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.